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Diminished Induction of Skin Fibrosis in Mice
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Ahalia M. Ferreira1, Shinsuke Takagawa2, Raoul Fresco3, Xiaofeng Zhu4, John Varga2 and Luisa A. DiPietro1
Scar and fibrosis are often the end result of mechanical injury and inflammatory diseases. One chemokine that
is repeatedly linked to fibrotic responses is monocyte chemoattractant protein-1 (MCP-1). We utilized a murine
fibrosis model that produces dermal lesions similar to scleroderma to evaluate collagen fibrillogenesis in the
absence of MCP-1. Dermal fibrosis was induced by subcutaneous injection of bleomycin into the dorsal skin of
MCP-1/ and wild-type C57BL/6 mice. After 4 weeks of daily injections, bleomycin treatment led to thickened
collagen bundles with robust inflammation in the lesional dermis of wild-type mice. In contrast, the lesional
skin of MCP-1/ mice exhibited a dermal architecture similar to phosphate-buffered saline (PBS)-injected
control and normal skin, with few inflammatory cells. Ultrastructural analysis of the lesional dermis from
bleomycin-injected wild-type mice revealed markedly abnormal arrangement of collagen fibrils, with normal
large diameter collagen fibrils replaced by small collagen fibrils of 41.5 nm. In comparison, the dermis of
bleomycin-injected MCP-1/ mice displayed a uniform pattern of fibril diameters that was similar to normal
skin (average diameter 76.7 nm). The findings implicate MCP-1 as a key determinant in the development of skin
fibrosis induced by bleomycin, and suggest that MCP-1 may influence collagen fiber formation in vivo.
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INTRODUCTION
When tissue is damaged, whether by mechanical trauma or
inflammation, the repair process is initiated. Under ideal
circumstances, inflammation quickly resolves, and tissue
repair occurs in a regulated fashion. However, in many
disease states, and sometimes even following minimal
traumatic insult, tissue repair becomes severely dysregulated,
and undue fibrosis results. Pathologic fibrosis is characterized
by excessive accumulation of extracellular matrix (ECM)
proteins (Knapp et al., 1977; Hunt, 1990). In normal
physiological tissue remodeling, a careful balance between
collagen synthesis and degradation is maintained, culminat-
ing in a final collagen content that is similar, although not
identical, to the original tissue (Parks, 1999). The matrix
metalloproteinases (MMPs) and their inhibitors (tissue in-
hibitor of metalloproteinases (TIMPs)) play a crucial role in
the maintenance of the normal balance between ECM
synthesis and degradation (Matrisian, 1992; Parks, 1999).
During fibrosis, the equilibrium shifts, and decreased levels of
MMPs and increased levels of TIMPs are thought to create an
environment that favors ECM accumulation.
In addition to the MMPs and their inhibitors, several other
proteins have been shown to modify collagen formation and
to influence the fibrotic response. Heat-shock protein 47
(HSP47), a collagen-specific intracellular chaperone, is
essential during the early stages of collagen biosynthesis.
Overexpression of HSP47 promotes collagen accumulation,
contributing considerably to the development of fibrotic
conditions (Masuda et al., 1994; Razzaque et al., 1998;
Dafforn et al., 2001).
In tandem with the net increase in collagen synthesis and
accumulation that occurs in fibrotic tissues, an altered
collagen ultrastructure is also apparent. Collagen fibrils in
fibrotic tissue are often smaller and less uniform in size than
fibrils in normal tissue (Fleischmajer et al., 1978; Lakos et al.,
2004). The assembly of collagen into fibrils is regulated by a
number of factors, including the small leucine-rich proteo-
glycans (Iozzo, 1997; Soo et al., 2000). Within this
proteoglycan family, several members, including decorin,
fibromodulin, and lumican, have a key function in collagen
assembly. Decorin, fibromodulin, and to a lesser degree,
lumican, bind to fibrillar collagen and influence fibril
diameter, tissue architecture, and strength (Soo et al., 2000).
Many studies suggest that the dysregulated collagen
synthesis that typifies a fibrotic response is initiated by solu-
ble mediators generated during uncontrolled inflammation.
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Monocyte chemoattractant protein-1 (MCP-1), a multifunc-
tional inflammatory chemokine belonging to the C–C
chemokine superfamily, has been shown to be upregulated
in a variety of fibrotic conditions. These include idiopathic
pulmonary fibrosis, systemic sclerosis, and bleomycin-in-
duced murine scleroderma (Rollins, 1996; Lloyd et al., 1997;
Hasegawa et al., 1999; Distler et al., 2001; Yamamoto and
Nishioka, 2003). The involvement of MCP-1 in these
pathological states has generally been thought to reflect its
pro-inflammatory role, as the generation of the inflammatory
milieu influences fibroblast function and collagen synthesis.
However, recent evidence suggests a more direct effect of
MCP-1 as well, as MCP-1 has now been shown to directly
upregulate type I collagen gene expression in rat lung
fibroblasts in vitro by modulating transforming growth
factor-beta (TGF-b) expression in fibroblasts themselves
(Gharaee-Kermani et al., 1996). In addition, MCP-1 also
induces increased levels of MMP-1 and -2, as well as TIMP-1,
in cultured skin fibroblasts. When taken together, these
observations indicate that in fibrotic diseases, the function of
MCP-1 may extend well beyond its role as a pro-inflamma-
tory mediator, and may include direct modulation of ECM
synthesis by the fibroblast.
The current study was performed in order to assess the
potential roles of MCP-1 in development of pathological
fibrosis. A well-established in vivo model of skin fibrosis was
used to evaluate both inflammation and collagen ultrastruc-
ture in the presence and absence of MCP-1. In this murine
model, subcutaneous injection of bleomycin produces a
dermal lesion that is histologically and biochemically similar
to that seen in scleroderma (Yamamoto et al., 1999). The
results presented here suggest that MCP-1 influences both
inflammation and collagen ultrastructure in this model.
RESULTS
Histologic comparison of bleomycin-induced lesions
in wild-type and MCP-1/ mice
The accumulation and organization of dermal collagen, and
the degree of fibrosis were compared between wild-type and
MCP-1/ mice that had received daily injections of
bleomycin for 4 weeks. Sections were subjected to Masson’s
trichrome stain, which permits areas of mature collagen
deposition to be detected. Skin lesions from bleomycin-
treated wild-type mice showed dense accumulation of thick
collagen bundles in the dermis, reflecting increased collagen
deposition. There was replacement of subcutaneous fat by
connective tissue (Figure 1a). Lesional dermis contained a
marked mononuclear cell infiltration, predominantly loca-
lized to the deeper layer (Figure 1a). In contrast, bleomycin
injection sites from MCP-1/ mice developed significantly
less dermal fibrosis and the subcutaneous fat was partially
preserved (Figure 1a). Mononuclear infiltration was also
reduced in skin lesions from MCP-1/ mice.
To provide a quantitative assessment of fibrosis, dermal
thickness was measured. In wild-type mice, the dermal
thickness of bleomycin lesions was increased 2-fold over
control phosphate-buffered saline (PBS)-injected sites (369.5
vs 150.3mm, Po0.0001). In contrast, in MCP-1/ mice,
bleomycin induced only a modest increase in dermal
thickness (Figure 1b). Interestingly, both PBS-injected (Figure
1b) and untreated skin (data not shown) of MCP-1/ mice
exhibited dermal thickness that was greater than in wild-type
mice. However, in contrast to wild-type mice, bleomycin
injection of MCP-1/ mice resulted in only a minimal (1.2-
fold) increase in dermal thickness compared with PBS-treated
controls (261.8 vs 196mm, P¼ 0.092) (Figure 1b). Therefore,
the fibrotic response induced by bleomycin was greatly
reduced in MCP-1/ mice compared to wild-type control.
Collagen fibril diameter following bleomycin injection
Following 4 weeks of daily bleomycin injections, the skin
from wild-type and MCP-1/ mice (n¼4) was examined by
transmission electron microscopy for changes in the ultra-
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Figure 1. Histological assessment of bleomycin-induced lesions in wild-type
(WT) and MCP-1/ mice. Photomicrographs of bleomycin-injected sites
from WT and MCP-1/ mice. (a) WT (left panels) and MCP-1/ (right
panels) mice received daily subcutaneous injections of PBS or bleomycin for
4 weeks. Lesional skin was harvested and examined by histology.
Representative sections stained with either hematoxylin and eosin (upper
panel) or Masson’s trichrome staining (lower panel) are shown (original
magnification  100). Insets in upper panels show a higher magnification
(original magnification  400), and demonstrate a higher degree of
inflammatory cell infiltration in lesions from WT than MCP-1/ mice.
Bar¼100 mm. (b) Dermal thickness was measured at five randomly selected
sites/field for PBS and bleomycin-injection sites in both WT and MCP-1 /
mice. Results are expressed as the means7SEM, *Po0.0001 versus WT PBS
treatment; **Po0.005 against WT bleomycin treatment. WT, n¼4,
MCP-1/ mice, n¼ 5.
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structure of collagen fibrils. In wild-type mice, the injection
of bleomycin led to a markedly abnormal arrangement of
collagen fibrils. The large diameter collagen fibrils that are
present in normal skin were largely replaced by small fibrils
in lesional skin (Figure 2a and b). Similar reductions in fibril
diameter have been described in fibrotic responses, and this
change is generally representative of active fibrosis and rapid
collagen synthesis (Kischer, 1974; Fleischmajer et al., 1978).
In contrast, skin from bleomycin-injected MCP-1/ mice
exhibited fibrils with a more uniform pattern of fibril diameter
and distribution, with an average diameter comparable to
that of normal skin (Figure 2). Morphometric analysis
demonstrated that the average collagen fibril diameter at
sites of bleomycin injection was significantly different in
MCP-1/ and wild type mice (76.776.1 vs 41.574.2 nm),
P¼0.0339 (Figure 2b). Surprisingly, measurement of cross-
sectional collagen fibrils from lesional skin from MCP-1/
mice also revealed the presence of very large fibrils up to
227 nm with abnormal shape, suggesting lateral fusion of
several adjacent fibrils. These fusions were not considered
when calculating collagen fibril diameter distributions (Figure
2a, right panel, inset).
Inflammatory cell and myofibroblast content in lesional skin
To characterize the degree and type of inflammatory cell
infiltration in the lesional dermis, immunohistochemical
markers were used to identify and quantify neutrophils,
macrophages, and T lymphocytes. When compared to wild-
type mice, bleomycin-treated skin from MCP-1/ mice
exhibited significantly fewer macrophages (11571.4 vs
57.173.5 per high-powered fields) (Figure 3a). Quantifica-
tion of neutrophils revealed that bleomycin-induced fibrotic
skin from MCP-1/ mice also contained significantly less
neutrophils than the corresponding lesion in wild-type mice
(11.471.3 vs 18.971.0 per high-powered fields) (Figure 3b).
In contrast to macrophages and neutrophils, the levels of CD3
positive T cells were not significantly different in bleomycin
skin from wild-type and MCP-1/ mice (Figure 3c). No
differences between wild-type and MCP-1/ mice were
seen for the numbers of neutrophils, macrophages, or T cells
in control sites that had been injected with PBS.
Increased myofibroblast accumulation in the dermis is a
key finding in scleroderma and is thought to contribute to
pathogenesis. To compare the accumulation of myofibro-
blasts in the lesional skin of wild-type and MCP-1/ mice,
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Figure 2. Ultrastructural analysis of collagen fibril content in lesional skin. (a) Transmission electronmicroscopy of untreated and bleomycin-treated skin, n¼ 4
for all groups. Transmission electronmicroscopy was performed to examine collagen fibril structure in the dermis of untreated normal skin (upper panels) and
bleomycin-treated skin (lower panels) from both WT (left panels) and MCP-1/ (right panels) mice. Bar¼100 nm. In bleomycin-treated lesional skin from WT
mice, the large diameter collagen fibrils normally seen in skin were replaced by smaller fibrils. In contrast, bleomycin-induced lesions from MCP-1/ mice
showed a pattern of fibril diameter and distribution (average diameter, 76.776.1 nm) quite similar to untreated normal skin. Inset: higher magnification of large
collagen fibrils with irregular shape that were seen in bleomycin-treated skin of MCP-1/ but not WT mice. These structures may represent fused collagen
fibrils. (b) Histograms of the distribution of collagen fibril diameter in untreated and bleomycin-treated skin of WT and MCP-1/ mice. The diameter of
individual collagen fibril was determined for between 1,170 and 2,665 fibrils per section. Two separate sections per mouse were examined and four
micrographs per mouse representing cross-sections of collagen fibrils were analyzed to generate the histograms. The relative frequency of collagen fibril
diameters is shown. The distribution of collagen fibrils in bleomycin-treated skin of WT and MCP-1/ strains was found to be significantly different
(P¼0.0339) by Wilcoxon rank-sum test. No significant difference in the distribution of collagen fibrils was found in PBS treatment groups.
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the expression of alpha-smooth muscle actin (a-SMA) was
examined by immunohistochemistry in multiple histologic
sections from four mice per group. In normal skin, a-SMA was
observed exclusively in vessels and erector pili muscles (data
not shown). a-SMA-positive cells other than erector pili were
also rare in the area of PBS injection in both wild-type and
MCP-1/ strains (Figure 4a and b). At bleomycin-injection
sites, however, myofibroblasts were consistently found to be
distributed throughout the dermis of the lesional skin of wild-
type mice. By comparison, bleomycin-injected lesional skin
from MCP-1/ mice consistently exhibited only rare
myofibroblasts (Figure 4c and d).
Analysis of TGF-b1 and MCP-1 levels
The levels of TGF-b1, as assessed by ELISA, were significantly
greater in bleomycin-treated wild-type mice compared to
MCP-1/ mice (0.8370.23 vs 0.4770.11 pg/mg of total
protein). In addition, there were no significant differences
between TGF-b1 levels of wild-type and MCP-1/ mice
treated with PBS. Similarly, dermal administration of bleo-
mycin resulted in a significant increase of MCP-1 levels in
wild-type mice when compared with mice treated with PBS
(64.579.9 vs 12.5972.42 pg/mg of total protein).
Differential expression of MMP and TIMPs in bleomycin-treated
wild-type and MCP-1/ mice
As dermal fibrosis may occur as a result of abnormalities in
the regulation of collagen synthesis and degradation, we
analyzed the expression levels of MMPs and their physiolo-
gical inhibitors, TIMPs, by RNase protection assay. As shown
in Figure 5, when compared to bleomycin-treated skin from
wild-type mice, bleomycin-treated skin from MCP-1/
mice showed a 3-fold increase in the MMP-13, TIMP-2,
and TIMP-3 expression levels. There were no remarkable
differences in TIMP-1 expression in the lesions of wild-type
and MCP-1/ mice. Further, no MMP-2, MMP-3, MMP-7,
MMP-8, MMP-9, and TIMP-4 expression was detected in any
group by this RNase protection assay.
Comparison of the gene expression profile of type I collagen,
decorin, fibromodulin, and HSP47 between MCP-1/ and
wild-type treated mice
Previous studies have demonstrated that the expression of
HSP47, decorin, and fibromodulin are associated with
increased deposition of collagen and modulation of collagen
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Figure 3. Quantitative immunohistochemical analysis of inflammatory cells
in lesions of WT and MCP-1/ mice. Histologic sections of lesional skin
from WT and MCP-1/ mice were subjected to immunohistochemical
staining with (a) anti-MOMA (macrophage marker), (b) anti-CD3 (T-cell
marker), and (c) anti-GR-1 (neutrophil marker) antibodies. The number of
positive cells was counted in five high-powered fields per section. The results
are expressed as means per five high-powered fields (200). n¼3 for WT
and n¼ 4 for MCP-1/ mice. Statistical analysis was performed using a
Student’s t-test. P-values o0.05 are shown.
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Figure 4. Immunohistochemical detection of myofibroblasts in lesional skin
from WT and MCP-1/ mice. a-SMA staining was performed on tissue
sections from (a and b) PBS or (c and d) bleomycin treated (a and c) WT
and (b and d) MCP-1/ mice. Dark stain indicates positive labeling
of myofibroblasts (closed arrow) as well as erector pili muscle (EP).
Representative photomicrographs are shown from four animals per group.
In WT mice, PBS-treated sites contained few a-SMA-positive cells. In contrast,
bleomycin-treated sites of WT mice consistently exhibited a-SMA-positive
cells throughout the dermis. In MCP-1/ mice, few a-SMA-positive
cells other than erector pili were seen in either PBS or bleomycin-injected
skin. Original magnification  200. (Color figure available online.)
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fibrillogenesis, contributing to the development of fibrosis
(Masuda et al., 1994; Danielson et al., 1997; Iozzo, 1997; Sini
et al., 1997; Razzaque et al., 1998; Chakravarti, 2002; Ishii
et al., 2003). To determine whether the expression of these key
fibrogenic genes was altered in MCP-1/ mice, semiquanti-
tative reverse transcriptase-PCR was used to determine relative
quantities of type I collagen, decorin, fibromodulin, and
HSP47 mRNAs in the bleomycin-injection sites. In keeping
with the concept that collagen synthesis was reduced in the
absence of MCP-1, type I collagen mRNA expression was
significantly lower (50%) in the dermis of bleomycin-treated
skin of MCP-1/ mice when compared to wild type (Figure
6a and b). Compared to wild-type lesions, HSP47 mRNA
levels were also decreased by approximately 50% in the
fibrotic lesions of MCP-1/ mice. In contrast, levels of
decorin mRNA were significantly increased by approximately
52% in MCP-1/ mice as compared to wild type. No
changes in fibromodulin expression were seen between the
experimental groups. Taken together, the data suggest that
MCP-1 has profound effects on the expression of multiple
factors that influence collagen formation and remodeling.
DISCUSSION
MCP-1, a member of the C–C chemokine family, has been
characterized as an important chemoattractant for mono-
nuclear cells during inflammation (Rollins, 1996). Recent
observations suggest that MCP-1 may be involved in the
complex series of events that ultimately result in fibrosis
(Yamamoto et al., 2000a; Yamamoto and Nishioka, 2003).
More specifically, antibody neutralization of MCP-1 has
been shown to decrease bleomycin-induced skin fibrosis
(Yamamoto and Nishioka, 2003). Our results support and
extend this observation.
MCP-1 is known to be pro-inflammatory, assisting in the
recruitment of monocytes and the activation of macrophages
(Fuentes et al., 1995). As expected, bleomycin injections
elicited a higher accumulation of macrophages in the lesional
skin of wild-type mice than in skin from MCP-1/ mice.
These findings are in concert with previous studies of skin
injury, as treatment with a neutralizing monoclonal anti-
MCP-1 resulted in a decrease in macrophage cell number in
dermal wounds (DiPietro et al., 2001). Together, the results
support the concept that MCP-1 plays a pivotal role by
mediating mononuclear cell recruitment and macrophage
activation. The recruited macrophages, via the production of
pro-fibrotic cytokines such as TGF-b, may then augment
matrix production, fibroblast proliferation, and myofibroblast
differentiation (Yamamoto and Nishioka, 2003).
The presence of myofibroblasts is consistent with the
pathology of fibrotic diseases (Sappino et al., 1990; Ludwicka
et al., 1992). Myofibroblasts are specialized cells with high
synthetic capacity for ECM proteins, namely collagen, as well
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Figure 5. Measurement of MMPs and TIMPs mRNA in lesions of wild type
(WT) and MCP-1/ mice. MCP-1/ (n¼ 5) and WT (n¼ 4) mice were
injected with bleomycin or PBS for 4 weeks. Total RNA was extracted from
lesional skin and the levels of various MMPs and TIMPs were compared by
RNase protection assay using RiboQuant MultiProbe. Densitometic analysis
of (a) MMP13, (b) TIMP2, and (c) TIMP3 mRNA expression. Specific mRNA
levels, detected by RNase protection assay, were normalized to GAPDH
expression. Data are representative of two independent experiments where
similar results were obtained. Statistical analysis was performed using a
Student’s t-test. P-values o0.05 are shown.
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Figure 6. Gene expression profile in skin from MCP-1/ and WT mice.
Total RNA was extracted from the skin from bleomycin- or PBS-treated WT
mice (n¼ 5) and MCP-1/ mice (n¼ 5). (a) Representative gel showing
reverse transcriptase-PCR products for murine type I collagen, decorin,
fibromodulin, and HSP47. Reverse transcriptase-PCR products were resolved
by electrophoresis in a 1.5% agarose gel and analyzed by densitometry. The
experiment was repeated two times with identical results. (b) Densitometric
analysis of gene expression in bleomycin treated skin. The results are depicted
graphically as the means7SE. Statistical analysis was performed using the
Student’s t-test. *Po0.05.
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as fibrogenic cytokines and chemokines (Gabbiani, 2003).
Using our model of bleomycin-induced fibrosis, we observed
that in addition to increased presence of myofibroblasts,
levels of MCP-1 and TGF-b protein were higher in lesional
skin of bleomycin-treated wild-type mice. Since MCP-1 is a
known inducer of TGF-b and this growth factor was not
increased in the skin of bleomycin-treated MCP-1/ mice,
our findings support the concept that MCP-1 sustains the
fibrotic process via the direct regulation of TGF-b and also
perhaps the consequent myofibroblast accumulation.
Whereas the modulation of inflammation by MCP-1 may
be important to the fibrotic response, our studies support the
concept of an additional non-inflammatory role for this
cytokine. When comparing wild-type and MCP-1/ mice,
the strain-specific differences in matrix organization and
collagen fibrillogenesis at the sites of bleomycin injection
were striking. In bleomycin-treated MCP-1/ mice, a
modest yet measurable dermal thickening exhibited a
collagen arrangement that was near-normal in appearance.
In contrast, in wild-type mice (and therefore in the presence
of MCP-1) robust dermal thickening was associated with
highly disorganized, primary small diameter fibrils, an
architecture associated with fibrotic reactions involving rapid
ECM accumulation (Kischer, 1974; Fleischmajer et al., 1978;
Kahari, 1993; Chen et al., 2003; Lakos et al., 2004). These
observations suggest that MCP-1 mediates a sequence of
events that ultimately results in the deposition of excess
collagen with fibrils that are smaller than in normal skin. The
reason for this change in fibrillar size in the lesions of the two
strains is not entirely clear. However, our results did reveal
that the accumulation of collagen observed in bleomycin-
treated skin from wild-type mice is accompanied with an
upregulation of HSP47 expression. Since HSP47 plays a
crucial role in collagen biosynthesis (Nagai et al., 2000), this
change may contribute to the increase synthesis and altered
assembly of collagen.
Recent compelling evidence has demonstrated that in
scleroderma and other fibrotic diseases, reduced ECM turn-
over is a contributory factor for collagen accumulation and
the development of dermal fibrosis (Nakamura et al., 1993;
Milani et al., 1994; Takeda et al., 1994; Arakawa et al., 1996;
Ghahary et al., 1996; Hayashi et al., 1996). In the MCP-1/
mice, enhanced ECM turnover may occur. The turnover of
the ECM depends upon the net MMP activity, a characteristic
that is derived from the balance between MMPs and TIMPs
(Swiderski et al., 1998; Young-Min et al., 2001; Toubi et al.,
2002; Sato et al., 2003; Gomez et al., 1997). Our data
demonstrates that, as compared to wild-type mice, the
balance between MMP and TIMP levels is shifted in the
bleomycin-induced lesions of MCP-1/ mice. In the
bleomycin-induced lesions in MCP-1/ mice, the levels
of TIMP-1, which preferentially inhibits the activity of the
collagenase MMP-13, remained at basal values, similar to
normal skin. MMP-13 levels were increased, a finding in
keeping with the concept that enhanced protease activity and
thus increased collagen turnover occurs in the lesions of the
MCP-1/ mice. However, the levels of TIMP-2 and TIMP-3
were also significantly upregulated in fibrotic tissue from
MCP-1/ mice. Since TIMP activity would inhibit proteo-
lysis and favor ECM accumulation, these data seems some-
what contradictory to the outcome of increased fibrosis. One
possible explanation may be that a substantial increased in
the biosynthesis or activity of MMP overcomes the effect of
the increased TIMP-2 and TIMP-3 levels, and therefore net
MMP levels remain greater in skin lesions from MCP-1/
mice than in wild-type mice.
One curious observation in the bleomycin lesions of MCP-
1/ mice was the occasional presence of very large fibrils
of about 300 nm with abnormal shape. The appearance of
these structures is suggestive of aberrant fibril fusion
products. Such fusions generally signify a failure to success-
fully maintain correct interfibrillar spacing. While the reason
for such fusion in the MCP-1/ mice is unknown, the
process may involve altered production of particular proteo-
glycans (Iozzo, 1997). Several members of the small leucine-
rich proteoglycans have been shown to interact with fibrillar
collagens and thus to influence fibrillar formation. Among
them, the appropriate levels of decorin, lumican, and
fibromodulin are known to be crucial to the maintenance
of correct interfibrillar spacing and to the assembly of the
collagen network (Schonherr et al., 1995; Weber et al.,
1996). In particular, the addition of exogenous decorin has
been shown to cause an increase in the diameter of type I
collagen fibrils (Kuc and Scott, 1997). Interestingly, our
studies demonstrate increased levels of decorin in MCP-1/
mice. This increase in decorin production might facilitate
collagen fibril fusion. Our results differed from those of
Yamamoto et al. who showed an increase in decorin
expression in fibroblasts in response to MCP-1 treatment
(Yamamoto and Nishioka, 2003). This difference may be due
to the fact that we examined total decorin expression within
fibrotic skin rather than in a primary cell isolate.
The present findings demonstrate a markedly diminished
response to fibrotic stimulus in the absence of MCP-1, and
are highly supportive of results from other studies in this and
other models (Moore et al., 2001; Gharaee-Kermani et al.,
2003; Yamamoto and Nishioka, 2003). Several of these
previous studies focused on the pro-inflammatory activity of
MCP-1, although a direct role for MCP-1 in modulating
fibroblast function has been proposed (Yamamoto and
Nishioka, 2003). Our results provide new information to
indicate that the loss of MCP-1 significantly alters the
assembly and accumulation of collagen, adds a new
dimension to our understanding of the role of MCP-1 in
fibrosis. Importantly, the findings suggest that the role of
MCP-1 in fibrosis is multi-factorial, and is not strictly limited
to inflammation. Ultimately, inhibition of MCP-1 might be a
therapeutic approach to the reduction of scar formation at
sites of injury.
MATERIALS AND METHODS
Animals
MCP-1/ mice, generated as previously described (Gu et al., 1999)
were received as homozygous breeder pair from Dr Barrett Rollins.
This MCP-1/ strain, originally derived in C57BL/6-129Sv/J, was
backcrossed more than eight generations on a C57BL/6 background
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prior to use in this study. This MCP-1/ strain is viable and fertile,
and was maintained in our colony as an inbred strain. As described
by others, C57BL/6 mice aged 7–8 weeks, obtained from Jackson
Laboratories, were used a control for the MCP-1/ mice (Lee et al.,
2003; Penido et al., 2003; Dewald et al., 2005). Compared to several
other strains, the C57BL/6 has been described to exhibit a reduced
level of bleomycin-induced skin fibrosis (Yamamoto et al., 2000b).
However, the response in this strain is easily measurable, allowing
us to use the C57BL/6 as an adequate control for comparison to the
MCP-1/ mice. The animals were maintained on a 12 hours light,
12 hours dark cycle and housed in the animal care facility at Loyola
University. All animal procedures followed institutional guidelines.
Each study group contained at least four mice.
Bleomycin treatment
Bleomycin (GensiaSicor Pharmaceuticals Inc. Irvine, CA) was
diluted to 0.1 U/ml with PBS, sterilized and filtered. Using a 27-
gauge needle, 100 ml of bleomycin or PBS was injected subcuta-
neously into a single location on the shaved back of MCP-1/ and
wild-type mice once daily for 1 or 4 weeks. At the end of the
experiments, mice were killed by euthanasia.
Histologic analyses of dermal thickness
Skin samples were obtained from the injected site and embedded in
paraffin. Sections (3–5mm) were cut, mounted on slides, and stained
with hematoxylin and eosin or Masson’s trichrome. Dermal
thickness was measured in hematoxylin and eosin sections viewed
under  100 microscopic magnification by measuring the distance
between the epidermal–dermal junction and the dermal-fat junction
at five randomly selected fields in two or more sections from each
animal.
Collagen fibril diameter assessment
Lesional skin from wild-type (n¼ 4) or MCP-1/ mice (n¼ 4) was
fixed in 4% glutaraldehyde and rinsed in 0.1 M sodium cacodylate
buffer. The samples were post-fixed in 1% osmium tetroxide,
dehydrated in graded alcohols, and embedded in Spurr’s epoxy
resin (Electron Microscopy Sciences; Fort, Washington, PA). Ultra-
thin sections (80 nm) were collected on grids, stained with uracyl
acetate and lead citrate and examined with a transmission electron
microscope (Hitachi H-600, 75 kv, Pleasonton, CA).
For each mouse, four micrographs representing cross-sections of
collagen fibrils were used for quantitative studies. The diameter of
between 1,170 and 2,665 individual collagen fibrils per section were
measured manually on photographic negatives with a calibrated
final original magnification of  30,000 and histograms were
generated. The relative frequency for each sample was calculated
by dividing the absolute frequency by the total number of data points
in the frequency distribution.
Analysis of inflammatory cell infiltrate
Immunohistochemistry was performed on frozen sections as
described previously (Swift et al., 1999). Briefly, tissue was
embedded in 22-oxacalcitriol (Sakura Finetek, Torrance, CA) and
snap frozen. Sections of 10 mm thickness were fixed in acetone for
15 minutes and endogenous peroxidase was blocked with hydrogen
peroxide in methanol. Excess proteins were blocked with either 10%
normal mouse serum or 10% goat serum for 30 minutes at room
temperature. The sections were then incubated for 30 minutes with
the primary monoclonal antibodies. For T-cell analysis, monoclonal
hamster anti-mouse CD3e (BD-Bioscience, San Jose, CA) was used.
For macrophages, rat anti-mouse macrophage antibody (MOMA-2,
1.7 mg/ml, Serotec Inc., Raleigh, NC) was used, and to analyze
neutrophils, rat anti-mouse GR-1 (5mg/ml, RB6-8C5, Pharmingen,
San Diego, CA) was used. Following incubation with the primary
antibody, sections were washed and incubated for 30 minutes with
biotinylated mouse anti-rat IgG (Jackson Immunoresearch, West
Grove, PA) at 13 mg/ml for macrophage and neutrophil staining and
with biotinylated goat anti-armenian hamster IgG for T cells.
Detection was performed using the ABC Elite kit (ABC, Vector
Laboratories, Burlingame, CA) followed by incubation in DAB
(Kirkegaard and Perry Laboratories, Gaithersburg, MD) for 4 minutes.
Finally, the sections were counterstained with hematoxylin (Sigma,
St Louis, MO), dehydrated through graded alcohols, and cover slips
were applied. For analysis of cell numbers, immunopositive cells
were counted in five high-powered fields ( 200) per section. The
number of positive stained cells was determined for two sections
per mouse, and the value expressed as the number of cells per five
high-powered fields.
Detection of myofibroblasts in wild-type and MCP-1/ tissue
Lesional skin from wild-type and MCP-1/ treated mice was
embedded in 22-oxacalcitriol media (Sakura Finetek, Torrance, CA).
Sections (10 mm) were cut, mounted on slides, and stained with an
antibody for a-SMA (clone 1A4, Sigma, St Louis, MO). Briefly, frozen
sections were air dried and fixed with acetone at 41C for 20 minutes
and then rehydrated in PBS for 3 minutes. Subsequently, hydrated
sections were quenched with H2O2 (0.3%) in 3% normal horse
serum for 15 minutes at room temperature. To block endogenous
mouse immunoglobulins, the MOM blocking kit (Vector, Burlin-
game, CA) was used according to the manufacturer’s instructions.
Slides were then incubated with the supplied biotinylated secondary
antibody, reacted with avidin–biotin complex (Vector, Burlingame,
CA), and developed with Novared chromogen (Sigma, St Louis,
MO), which yields a red color indicating positive staining. Sections
were counterstained with hematoxylin, mounted, and analyzed
using a Zeiss Axioskop 2 equipped with a Zeiss AxioCam HRc
camera (Carl Zeiss, Thornwood, NY). Tissue was collected from four
animals per experimental condition, and three sections from each
mouse were subjected to immunohistochemical staining for a-SMA-
positive cells. A blinded observer examined at least three high-
power fields per section. The relative levels of a-SMA-positive cells
in lesional, bleomycin-injected sites was described in comparison to
levels in control, PBS-injected sites.
Analysis of MMP and TIMP gene expression
Total RNA was isolated from bleomycin- and PBS-treated skin from
wild-type and MCP-1/ mice using Trizol (Invitrogen, Carlsbad,
CA), according to the manufacturer’s guidelines. Of total RNA, 3 mg
was analyzed with the RiboQuant multiprobe RNase protection
assay and the mMMP-1 and mMMP-2 mouse metalloproteinase
riboprobe template set (BD PharMingen, San Diego, CA) encoding
MMP-13, MMP-2, MMP-3, MMP-7, MMP-8, MMP-9, MMP-12, and
their inhibitors TIMP-1, TIMP-2, TIMP-3, TIMP-4. Two controls, L32
and glyceraldhehyde-3-phosphate-dehydrogenase (GAPDH), were
also included in the template set. The hybridization products were
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resolved on a polyacrylamide sequencing gel. The gels were dried at
801C for 1 hour and the mRNA bands were detected with the FX
Molecular phosporimaging system. Chemokine mRNA quantifica-
tion was performed using QuantiOne Molecular Imaging Software
(Bio-Rad, Hercules, CA) and the chemokine mRNA bands were
normalized to GAPDH bands and the results were expressed as
relative OD units (ODgene band/ODGAPDH).
Analysis of HSP47, type 1 collagen, decorin, and fibromodulin
gene expression
Total RNA was extracted from lesional and normal skin biopsy tissue
from wild-type (n¼ 5) and MCP-1/ mice (n¼ 5) using Trizol
(Invitrogen). Of total RNA, 1mg was reversed transcribed and
amplified using the following primers: HSP47 sense 50-ACCACAG
GATGGTGGACAACCGT-30, antisense 50-ATCTCGCATCTTGTCTC
CCTTGGG-30; decorin sense 50-AGTCACAGGGCAGCACCAC-30,
antisense 50-GGGGATTGTCAGGGTCATAAGG-30; fibromodulin
sense 50-TGACACAACATGATCTGCAC-30, antisense 50-TTCTTGC
ACCCCAGTGAGCA-30; type I collagen sense 50-TGGTGCCAA
GGGTCTCACTGGC-30, antisense 50-GGACCTTGTACACCACGT
CGTTCACC-30; GAPDH sense 50-TGATGACATCAAGAAGGTGGT
GAAG-30, antisense 50-TCCTTGGAGGCCATGTAGGCCAT-30. Re-
verse transcriptase-PCR products were resolved by electrophoresis in
a 1.5% agarose gel containing GelStar nucleic acid stain (FMC
Bioproducts, Rockland, ME). The bands were visualized and the gels
were photographed using a molecular FX Imaging station and Gel
Doc (Bio-Rad, Hercules, CA). The optimal number of PCR cycles for
each gene was chosen so that all signals for each gene were within
the exponential phase.
Protein isolation and ELISA analysis
Lesional and normal skin biopsy tissue from wild-type (n¼ 3) and
MCP-1/ mice (n¼ 3) was homogenized in protease inhibitor
buffer (PBS containing complete protease inhibitor cocktail tablet;
Roche Diagnostics, Mannheim, Germany), sonicated, and centri-
fuged at 10,000 r.p.m. for 10 minutes. Supernatants were used to
analyze TGF-b1 and MCP-1 levels by ELISA following the
manufacturer’s instructions (R&D systems, Minneapolis, MN). TGF-
b1 and MCP-1 levels in pg were normalized to total protein
concentrations as determined by the Bio-Rad Protein Assay (Bio-Rad,
Hercules, CA).
Statistical analysis
All results were evaluated using Graph Pad Prism 4.0 software, and
analyzed by a two tailed t-test. Data are represented as mean7SEM.
For all analyses, Po0.05 was considered significant. For morpho-
metric analysis of collagen fibril diameters, the relative frequency
was calculated and the collagen fibril diameter distributions were
presented as histograms. Distribution of the means for MCP-1/
mice was compared with the wild-type group using Wilcoxon Rank-
Sum test.
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